SpaceX’s $75B IPO oversubscribed, set for June 12 debut
SpaceX IPO Closing Market Cap Above Thresholds
Share
Add us on Google by Estefano Gomez Jun. 5, 2026SpaceX, the aerospace company founded by Elon Musk, has announced that its $75 billion initial public offering (IPO) is already oversubscribed, according to investor reports. The IPO, priced at $135 per share, could value the company at approximately $1.8 trillion, with activity set to begin on June 12. The offering stands out due to its use of a fixed-price structure, diverging from the typical variable price range seen in many IPOs. The oversubscription suggests strong market confidence in SpaceX’s strategic positioning in U.S. space and defense sectors.
AdvertisementKey Takeaways
- Market oversubscription appears to suggest strong investor demand for SpaceX’s IPO, potentially supportive of a high market valuation.
- Pricing suggests market participants view the likelihood of SpaceX’s IPO proceeding by June 30 as very high, consistent with positive market sentiment.
- The fixed-price structure could indicate confidence in the set valuation, aligning with expectations of a robust market debut.
What to Watch
As June 12 approaches, market participants will be closely observing any updates on underwriter reports or changes in investor sentiment. Key factors include any announcements from SpaceX about strategic partnerships or technological advancements that could influence valuation perceptions. Additionally, regulatory approvals from the SEC and listing announcements from exchanges like NASDAQ or NYSE will be pivotal in confirming the IPO timeline and structure. Monitoring these developments will provide further insights into how the IPO may be received by the wider market.
Classifier accuracy: 28/153 (18%) correct on market direction (4hr window).
Get prediction market intelligence as a structured API feed. Early access waitlist.
Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.
